JAPANESE HEART JOURNAL, vol.45, no.4, pp.613-621, 2004 (SCI-Expanded)
Octreotide, a somatostatin analogue, has been found effective in the treatment of acromegalic cardiomyopathy. We investigated whether intermittent octreotide therapy had beneficial effects in patients with ischemic or idiopathic dilated cardiomyopathy, which are refractory to conventional therapy.